Skip to main content

Companies researching Induced pluripotent stem cells (ipscs)

Induced pluripotent stem cells (iPSCs) are lab‑generated stem cells created by reprogramming adult skin or blood cells to an embryonic‑like state, providing an unlimited source of human cells for therapeutic and regenerative medicine research.

2,110

companies

List of companies that research Induced pluripotent stem cells (ipscs)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Security and Investigations

1k

$7.2M

Induced pluripotent stem cells (ipscs)

United States

Oil and Gas

3.3k

Induced pluripotent stem cells (ipscs)

United States

Biotechnology Research

21k

$26B

Induced pluripotent stem cells (ipscs)

United States

Hospitals and Health Care

18k

$484M

Induced pluripotent stem cells (ipscs)

United Kingdom

Higher Education

23k

$171M

Induced pluripotent stem cells (ipscs)

Switzerland

Biotechnology Research

107k

$68B

Induced pluripotent stem cells (ipscs)

France

Pharmaceutical Manufacturing

93k

$46B

Induced pluripotent stem cells (ipscs)

France

Research Services

550

Induced pluripotent stem cells (ipscs)

United States

Higher Education

14k

$2.3B

Induced pluripotent stem cells (ipscs)

France

Research Services

23k

$675M

Induced pluripotent stem cells (ipscs)

Showing top companies out of 2,110 that research Induced pluripotent stem cells (ipscs). Get the full list on TheirStack.

Frequently asked questions